Analysts are bullish on Injective (INJ), Mirror Protocol (MIR), and KangaMoon (KANG) in Q1 2024
Originally appeared here:
Investors closely tracking Injective, Mirror Protocol, and KangaMoon in Q1 2024
Originally appeared here:
Investors closely tracking Injective, Mirror Protocol, and KangaMoon in Q1 2024